ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Epidemiology and Public Health - Poster III

Date: Tuesday, November 15, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM
Abstract Number: 2160
Allopurinol Use and the Risk of Acute Cardiovascular Events in Patients with Gout and Diabetes
9:00AM-11:00AM
Abstract Number: 2159
Allopurinol Use Is Associated with Lower Risk of Peripheral Vascular Disease in the US Elderly
9:00AM-11:00AM
Abstract Number: 2186
Analgesic Use and Subsequent Risk of Falls in Participants with or at Risk of Knee Osteoarthritis
9:00AM-11:00AM
Abstract Number: 2161
Association Between Inflammation and Systolic Blood Pressure at Normal and High C-Reactive Protein Levels
9:00AM-11:00AM
Abstract Number: 2180
Association of Anterior Cruciate Ligament/Meniscal Injury with Knee Function, Knee Pain, and Knee Osteoarthritis in Military Officers
9:00AM-11:00AM
Abstract Number: 2170
Cardiovascular Risk in Patients with Psoriasis, Psoriatic and Rheumatoid Arthritis: A Prospective Study Using Secured Anonymised Information Technology Databank in Wales, United Kingdom
9:00AM-11:00AM
Abstract Number: 2176
Comorbidities and DMARD, NSAID and Steroid Use in a Real Life Cohort of 8,981 Patients with Psoriatic Arthritis
9:00AM-11:00AM
Abstract Number: 2175
Comparisons of Patients Prescribed Biosimilars or BIO-Originators for Autoimmune Diseases in Germany
9:00AM-11:00AM
Abstract Number: 2164
Depression and the Risk of Psoriatic Arthritis Among Patients with Psoriasis: A Population-Based Cohort Study
9:00AM-11:00AM
Abstract Number: 2163
Depressive Symptoms in Patients Consulting for the First Time at the Division of Rheumatology
9:00AM-11:00AM
Abstract Number: 2174
Effect of Anti-Rheumatic Treatment on Selenium Levels in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
9:00AM-11:00AM
Abstract Number: 2184
Evidence Based Physical Activity Threshold to Predict Improved/High Function in Older Adults with Lower Extremity Conditions: The Osteoarthritis Initiative
9:00AM-11:00AM
Abstract Number: 2162
Frequent Discussion of Insomnia and Weight Gain with Glucocorticoid Therapy: An Analysis of Twitter Posts
9:00AM-11:00AM
Abstract Number: 2181
High Dietary Fiber Intake Is Associated with Lower Likelihood of Severe Knee Pain Trajectory
9:00AM-11:00AM
Abstract Number: 2172
Impact of Biologic and Non-Biologic Treatment on the Incidence of Traditional Cardiovascular Risk Factors Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis
9:00AM-11:00AM
Abstract Number: 2171
Increased Rates of Hypertension in Patients with Psoriatic Arthritis Compared to Psoriasis Alone: Results from the UK Biobank
9:00AM-11:00AM
Abstract Number: 2166
Inflammatory Arthropathy and Hashimoto’s Thyroiditis: Prevalence and Associated Factors
9:00AM-11:00AM
Abstract Number: 2182
Levels of Severity of Hip and Knee OA – Validation of Lay Descriptions
9:00AM-11:00AM
Abstract Number: 2168
Metabolic Syndrome, All Cause Mortality and Atherosclerotic Cardiovascular Disease in Rheumatic Diseases
9:00AM-11:00AM
Abstract Number: 2165
Natural Language Processing to Rapidly Identify Potential Signals for Adverse Events Using Electronic Medical Record Data: Example of Arthralgias and Vedolizumab
9:00AM-11:00AM
Abstract Number: 2173
Patient Reported Disease Activity and Efficacy of Biologic Therapy in Patients with Psoriatic Arthritis. an Observational Study of 107 Patients of the Estonian Society for Rheumatology Biologic Therapy Register during 2008-2014
9:00AM-11:00AM
Abstract Number: 2169
Presence of Cardiovascular Risk Factors Across Different Inflammatory Joint Disease Entities: Results from a Norwegian, Multi-Centre Project
9:00AM-11:00AM
Abstract Number: 2185
Prevalence and Trends in Prescribed Opioid Use Among US Adults with Arthritis, 2008-2013, Medical Expenditure Panel Survey
9:00AM-11:00AM
Abstract Number: 2158
Serum Uric Acid Is Positively Associated with Pulmonary Function in Korean Health Screening Examinees: A Cross-Sectional Study
9:00AM-11:00AM
Abstract Number: 2177
Specificity of Spinal Pain Features in Assessment and Classification of Spondyloarthritis
9:00AM-11:00AM
Abstract Number: 2178
Statin Use and Increased Risk of Musculoskeletal Conditions: A Retrospective Cohort Study with Propensity Score-Matching
9:00AM-11:00AM
Abstract Number: 2183
The Electronic Osteoarthritis Knee and Hip Quality of Life (OAKHQOL) Questionnaire: A Useful and Valid Alternative to Measure Health-Related Quality of Life in Knee Osteoarthritis 
9:00AM-11:00AM
Abstract Number: 2167
Validation of the Earp Questionnaire: Detection of Psoriatic Arthritis in the Spanish Population
9:00AM-11:00AM
Abstract Number: 2187
Vitamin D Levels and Fragility Fractures in Postmenopausal Portuguese Women- Results from Epireumapt
9:00AM-11:00AM
Abstract Number: 2179
What Are the Risk Factors for Knee Pain, Radiographic Knee Osteoarthritis and Total Knee Replacement in Professional Footballers?

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology